CytomX Therapeutics
Total Raised
$133.61MInvestors Count
16Deal Terms
6Funding, Valuation & Revenue
9 Fundings
CytomX Therapeutics has raised $133.61M over 9 rounds.
CytomX Therapeutics's latest funding round was a IPO for $80M on October 8, 2015.
CytomX Therapeutics's latest post-money valuation is from October 2015.
Sign up for a free demo to see CytomX Therapeutics's valuations in October 2015 and more.
Date | Round | Amount | Investors | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Revenue | Sources |
|---|---|---|---|---|---|---|
10/8/2015 | IPO | $80M | 1 | |||
6/17/2015 | Series D | |||||
1/6/2015 | Series C | |||||
4/29/2014 | Series B - III | |||||
7/31/2012 | Series B - II |
Date | 10/8/2015 | 6/17/2015 | 1/6/2015 | 4/29/2014 | 7/31/2012 |
|---|---|---|---|---|---|
Round | IPO | Series D | Series C | Series B - III | Series B - II |
Amount | $80M | ||||
Investors | |||||
Valuation | |||||
Revenue | |||||
Sources | 1 |
CytomX Therapeutics Deal Terms
6 Deal Terms
CytomX Therapeutics's deal structure is available for 6 funding rounds, including their IPO from October 08, 2015.
Round | IPO | Series D | Series C | Series B - III | Series B - II |
|---|---|---|---|---|---|
Funding Date | |||||
Pre-Money Valuation | |||||
Post-Money Valuation | |||||
Amount Raised | |||||
Shares Authorized | |||||
Issuance Price | |||||
Dividend Rate | |||||
Liquidation Preferences | |||||
Liquidation Price | |||||
Participation | |||||
Conversion Price | |||||
Anti Dilution | |||||
General Voting | |||||
Board Voting | |||||
Par Value |
Round | Funding Date | Pre-Money Valuation | Post-Money Valuation | Amount Raised | Shares Authorized | Issuance Price | Dividend Rate | Liquidation Preferences | Liquidation Price | Participation | Conversion Price | Anti Dilution | General Voting | Board Voting | Par Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
IPO | |||||||||||||||
Series D | |||||||||||||||
Series C | |||||||||||||||
Series B - III | |||||||||||||||
Series B - II |
CytomX Therapeutics Investors
16 Investors
CytomX Therapeutics has 16 investors. abrdn invested in CytomX Therapeutics's Series D funding round.
First funding | Last Funding | Investor | Rounds | Board Seats | Type | Location |
|---|---|---|---|---|---|---|
6/17/2015 | 6/17/2015 | 1 Series D | Asset/Investment Management | Massachusetts | ||
6/17/2015 | 6/17/2015 | 1 Series D | Hedge Fund | California | ||
6/17/2015 | 6/17/2015 | 1 Series D | Asset/Investment Management | Massachusetts | ||
Investment Bank | Massachusetts | |||||
Asset/Investment Management | Massachusetts |
First funding | 6/17/2015 | 6/17/2015 | 6/17/2015 | ||
|---|---|---|---|---|---|
Last Funding | 6/17/2015 | 6/17/2015 | 6/17/2015 | ||
Investor | |||||
Rounds | 1 Series D | 1 Series D | 1 Series D | ||
Board Seats | |||||
Type | Asset/Investment Management | Hedge Fund | Asset/Investment Management | Investment Bank | Asset/Investment Management |
Location | Massachusetts | California | Massachusetts | Massachusetts | Massachusetts |
Loading...